Science

Jul 19, 2025, 17:26

Myeloma Paper of the Day, July 19th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Residual disease assessed with whole body MRI per MY-RADS protocol linked to shorter PFS (median 24 vs. 42 months) and OS (median 47 months vs. NE) in newly diagnosed or at first relapse patients undergoing first ASCT.”

Title: Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma

Authors: Christina Messiou, Nuria Porta, Dow-Mu Koh, Angela Riddell, Katherine Downey, James Croft, Leonora Conneely, Georgina Hopkinson, Alina Dragan, Tommy Brown, Simon Stern, Betty Cheung, Charalampia Kyriakou, Pawel Kaczmarek, Kevin Boyd, Charlotte Pawlyn, Jessica Winfield, Martin F. Kaiser

You can read the Full Article in Blood Cancer Journal.

Myeloma Paper of the Day, July 19th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Alina Dragan Angela Riddell ASCT Betty Cheung Blood Cancer Journal cancer Charalampia Kyriakou Charlotte Pawlyn Christina Messiou Dow-Mu Koh Georgina Hopkinson James Croft Jessica Winfield Katherine Downey Kevin Boyd Leonora Conneely Martin F. Kaiser MRI MY-RADS Myeloma Myeloma Paper of the Day Nuria Porta OncoDaily Oncology Pawel Kaczmarek Robert Orlowski Simon Stern Tommy Brown

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer